Sequences

Sample result

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

GLP-1, a diabetes hormone

Protein → Patent proteins · Automatic (Smith-Waterman)

Download as Excel

Every list and the search record, one sheet each.

Query
GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
Set
Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
5,000 sequences, 3,061 publications, 1,851 families

Charts

Identity against coverage

5,000 hits by identity and query coverage. 5,000 with a date.

Has a date707075758080858590909595100100Identity (%)Query coverage (%)
Show table
Hits by identity
BandHas a dateAll
100%553553
95 to 99.9%992992
90 to 94.9%2,6382,638
80 to 89.9%814814
70 to 79.9%33
Hits by query coverage
BandHas a dateAll
100%3,6063,606
95 to 99.9%876876
90 to 94.9%483483
80 to 89.9%3535

Hits by year

1,851 families by year of first publication, 1990 to 2026.

Has a dateFamilies0501001502001990199319961999200220052008201120142017202020232026
Show table
Families by year of first publication
YearHas a dateAll
199022
199222
199311
199411
199511
199633
199722
199822
19991111
20001313
20011919
20023434
20032626
20043131
20054444
20065050
20075959
20086060
20097878
20105757
20117272
20127474
20137777
20146969
20158181
20167676
20178282
20187979
20197777
20208787
2021106106
20228585
20239191
20249191
2025151151
20265757

Where hits align on the query

The top 20 hits on GLP-1, a query of 31 amino acids: 20 cover the whole query, none differs from it.

Aligned partDiffers from the queryGLP-1 · 31 amino acids151015202531HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRGAAA55132.1A31422.1AAB11984.1DI506186DI527435AAB11995.1AAE02614.1DI540976DI521338DI502216DJ789879DI520483AAE49428.1AAE49430.1AAE49429.1AAE49432.1DI501808AAY78103.1BD613525BD613528
Show table
The top 20 hits on GLP-1, positions on the query
HitQuery fromQuery toIdentityDiffers atGaps atX at
AAA55132.1131100.0%NoneNoneNone
A31422.1131100.0%NoneNoneNone
AAB11984.1131100.0%NoneNoneNone
DI506186131100.0%NoneNoneNone
DI527435131100.0%NoneNoneNone
AAB11995.1131100.0%NoneNoneNone
AAE02614.1131100.0%NoneNoneNone
DI540976131100.0%NoneNoneNone
DI521338131100.0%NoneNoneNone
DI502216131100.0%NoneNoneNone
DJ789879131100.0%NoneNoneNone
DI520483131100.0%NoneNoneNone
AAE49428.1131100.0%NoneNoneNone
AAE49430.1131100.0%NoneNoneNone
AAE49429.1131100.0%NoneNoneNone
AAE49432.1131100.0%NoneNoneNone
DI501808131100.0%NoneNoneNone
AAY78103.1131100.0%NoneNoneNone
BD613525131100.0%NoneNoneNone
BD613528131100.0%NoneNoneNone

Patents 3.1K

Columns
Tick the columns each row shows, then choose Show. The arrows move a column.

3,061 publications in 1,851 families match these filters.

  1. JP 2011173886-A2011-09-08

    Modified Exendins and uses thereof

    WUXI GRANDCHAMP PHARMACEUTICAL TECHNOLOGY CO LTD

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  2. EP 2368909-A12011-09-28

    GLP-1 analog fusion proteins

    LILLY CO ELI

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  3. EP 2371378-A12011-10-05

    Modification of feeding behaviour and weight control by oxyntomodulin

    IMP INNOVATIONS LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  4. US 8039432-B22011-10-18

    Method of treatment of diabetes and/or obesity with reduced nausea side effect

    Conjuchem, LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  5. EP 2376097-A12011-10-19

    AMIDE BASED GLUCAGON SUPERFAMILY PEPTIDE PRODRUGS

    UNIV INDIANA RES & TECH CORP

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  6. SERUM ALBUMIN BINDING MOLECULES

    SQUIBB BRISTOL MYERS CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  7. US 8066994-B22011-11-29

    Proteins comprising an IgG2 domain

    Merck Patent GmbH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  8. US 8071110-B22011-12-06

    Activatable clostridial toxins

    Allergan, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

  9. US 8080516-B22011-12-20

    Long lasting synthetic exendin-4 peptide conjugates

    Conjuchem, LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  10. US 8084414-B22011-12-27

    Methods involving long lasting synthetic exendin-4-peptide conjugates

    Conjuchem, LLC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  11. PROTEASE VARIANTS OF HUMAN NEPRILYSIN

    MEDIMMUNE LLC

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  12. JP 2012500017-A2012-01-05

    GLP-1 Fusion Proteins

    Asterion Limited

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  13. US 8097239-B22012-01-17

    Controlled-release formulations

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  14. US 8097586-B22012-01-17

    Modified exedins and uses thereof

    Wuxi Grandchamp Pharmaceutical Technology Co., Ltd.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  15. EP 2413955-A22012-02-08

    N-TERMINUS CONFORMATIONALLY CONSTRAINED GLP-1 RECEPTOR AGONIST COMPOUNDS

    AMYLIN PHARMACEUTICALS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  16. US 8114632-B22012-02-14

    Method of producing biologically active polypeptide having insulinotropic activity

    Biocon Limited

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  17. US 8138305-B22012-03-20

    Analogues of GLP-1

    Ipsen Pharma S.A.S.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  18. PRODRUGS COMPRISING AN EXENDIN LINKER CONJUGATE

    SANOFI AVENTIS DEUTSCHLAND

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  19. EP 2435061-A12012-04-04

    GLP-1 RECEPTOR AGONIST COMPOUNDS FOR SLEEP ENHANCEMENT

    AMYLIN PHARMACEUTICALS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  20. US 8158583-B22012-04-17

    Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia

    Novo Nordisk A/S

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  21. JP 2012510798-A2012-05-17

    PEPTIDE THERAPEUTIC CONJUGATES AND USES THEREOF

    ANGIOCHEM INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  22. DOUBLE-ACYLATED GLP-1 DERIVATIVES WITH A LINKER

    NOVO NORDISK AS

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  23. JP 2012512898-A2012-06-07

    DIPEPTIDE LINKED MEDICINAL AGENTS

    Richard DiMarchi

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  24. JP 2012512903-A2012-06-07

    Amida Based Glucagon and Related Peptide Prodrugs

    DiMarchi et al

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, US 61/139210.

  25. SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID

    NOVO NORDISK AS

    Query Match 100.0%Identity 100.0%Family of 14

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 14

    Grouped by the same title and applicant. No priority claim is on record.

  26. EP 2468858-A12012-06-27

    FUSION PROTEIN REGULATING PLASMA GLUCOSE AND LIPID, ITS PREPARATION METHOD AND USE

    CHONGQING FAGEN BIOMEDICAL INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  27. GLUCAGON ANALOGS EXHIBITING GIP RECEPTOR ACTIVITY

    UNIV INDIANA RES & TECH CORP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  28. US 8211439-B22012-07-03

    Albumin fusion proteins comprising insulin polypeptides

    Human Genome Sciences, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

  29. US 8227571-B22012-07-24

    Insulinotropic peptide synthesis using solid and solution phase combination techniques

    Roche Palo Alto LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  30. BIOMARKERS FOR RAPID DETERMINATION OF DRUG EFFICACY

    IR2DX INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

  31. EP 2482840-A22012-08-08

    VAL (8) GLP-1 COMPOSITION AND METHOD FOR TREATING FUNCTIONAL DYSPEPSIA AND/OR IRRITABLE BOWEL SYNDROME

    MANNKIND CORP

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  32. EP 2494062-A22012-09-05

    ANTI-GLP-1R ANTIBODIES AND THEIR USES

    JANSSEN BIOTECH INC

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  33. EP 2494983-A12012-09-05

    Stable formulations of GLP-1

    NOVO NORDISK AS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  34. EP 2495255-A12012-09-05

    GLYCOSYLATED FORM OF ANTIGENIC GLP-1 ANALOGUE

    OTSUKA CHEMICAL CO LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  35. US 8263554-B22012-09-11

    Methods of using GLP-1 receptor agonists to treat pancreatitis

    Amylin Pharmaceuticals, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  36. EP 2496249-A22012-09-12

    GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA

    AMYLIN PHARMACEUTICALS INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  37. WO 2012121302-A2012-09-13

    An analysis method

    SANWA KAGAKU KENKYUSHO Co LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  38. BLOOD COLLECTION DEVICE CONTAINING LYSOPHOSPHOLIPASE INHIBITOR

    BECTON DICKINSON CO

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  39. US 8268781-B22012-09-18

    Peptide derivatives of exendin-4

    Philipps-Universitat Marburg

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  40. US 8288339-B22012-10-16

    GLP-1 compounds

    Amgen Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  41. US 8293869-B22012-10-23

    Polymer conjugates of GLP-1

    Nektar Therapeutics

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  42. JP 2012526524-A2012-11-01

    Treatment of eye diseases using encapsulated cells encoding and secreting an anti-angiogenic and/or a neuroprotective factor

    Biocompatibles UK Limited

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  43. WO 2012153620-A2012-11-15

    Medicine, functional food, target protein stabilization method, fusion protein, nucleic acid, and recombinant

    Sekisui Chemical Co Ltd

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, JP 2011-240593.

  44. JP 2012530145-A2012-11-29

    GIP RECEPTOR-ACTIVE GLUCAGON COMPOUNDS

    INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  45. PEPTIDE CONTROLLED-RELEASE FORMULATIONS

    CAMURUS AB

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  46. EP 2528618-A12012-12-05

    GLUCAGON ANTAGONIST - GIP AGONIST CONJUGATES AND COMPOSITIONS FOR THE TREATMENT OF METABOLIC DISORDERS AND OBESITY

    UNIV INDIANA RES & TECH CORP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  47. JP 2012530498-A2012-12-06

    PROTEASE VARIANTS

    MEDIMMUNE LLC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  48. US 8329419-B22012-12-11

    GLP-1 receptor agonist bioassays

    Amylin Pharmaceuticals, LLC and Astrazeneca Pharmaceuticals LP

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  49. Composition for Treating Diabetes Comprising Long-acting Insulin Conjugate and Long-acting Insulinotropic Peptide Conjugate

    Hanmi Science Co., Ltd

    Query Match 100.0%Identity 100.0%Family of 5

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 5

    Grouped by the same title and applicant. No priority claim is on record.

  50. EP 2555791-A12013-02-13

    METHODS FOR TREATING DISORDERS OF THE GASTROINTESTINAL TRACT USING A GLP-1 AGONIST

    MT SINAI HOSPITAL

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.